How Scleroderma Affects the Lungs

Wendy Henderson avatar

by Wendy Henderson |

Share this article:

Share article via email

In this video from the Greater Chicago Chapter of the Scleroderma Foundation, we see a presentation from the Scleroderma Patient Education Conference, held on October 15, 2016 in Chicago.

PAH Medications Tracleer and Opsumit, seen to block fibrosis in scleroderma. Find out more. 

Dr. Dematte from the Division of Pulmonary and Critical Care at the Northwestern Feinberg School of Medicine in Chicago, explains how scleroderma can affect the lungs, resulting in different pulmonary conditions. She talks about interstitial lung disease, aspiration lung injury, and pulmonary arterial hypertension (PAH) and how patients are more at risk of developing a scleroderma-related chronic lung disease.

Ten parts of the body that can be affected by scleroderma.

Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.